These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 25310960
21. Bone mineral content and mineral metabolism during cyclosporine treatment of nephrotic Syndrome. Freundlich M. J Pediatr; 2006 Sep; 149(3):383-9. PubMed ID: 16939753 [Abstract] [Full Text] [Related]
22. Abnormalities of the PTH-vitamin D axis and bone turnover markers in children, adolescents and adults with cystic fibrosis: comparison with healthy controls. Greer RM, Buntain HM, Potter JM, Wainwright CE, Wong JC, O'Rourke PK, Francis PW, Bell SC, Batch JA. Osteoporos Int; 2003 Jun; 14(5):404-11. PubMed ID: 12730764 [Abstract] [Full Text] [Related]
23. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA. N Engl J Med; 2004 Aug 26; 351(9):868-75. PubMed ID: 15329424 [Abstract] [Full Text] [Related]
24. Biochemical bone markers, bone mineral content, and bone mineral density in rats with experimental nephrotic syndrome. Sierra RI, Specker BL, Jiménez F, Cruz C, Pedraza-Chaverrí J. Ren Fail; 1997 May 26; 19(3):409-24. PubMed ID: 9154658 [Abstract] [Full Text] [Related]
25. Bone status and adipokine levels in children on vegetarian and omnivorous diets. Ambroszkiewicz J, Chełchowska M, Szamotulska K, Rowicka G, Klemarczyk W, Strucińska M, Gajewska J. Clin Nutr; 2019 Apr 26; 38(2):730-737. PubMed ID: 29609869 [Abstract] [Full Text] [Related]
26. Impairment of bone mass development in children with chronic cholestatic liver disease. de Albuquerque Taveira AT, Fernandes MI, Galvão LC, Sawamura R, de Mello Vieira E, de Paula FJ. Clin Endocrinol (Oxf); 2007 Apr 26; 66(4):518-23. PubMed ID: 17371469 [Abstract] [Full Text] [Related]
27. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L. Am J Med; 1996 Sep 26; 101(3):262-9. PubMed ID: 8873487 [Abstract] [Full Text] [Related]
28. Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy. Madeddu G, Spanu A, Chessa F, Calia GM, Lovigu C, Mannazzu M, Falchi A, Sanna D, Mura MS, Madeddu G. Q J Nucl Med Mol Imaging; 2009 Jun 26; 53(3):290-301. PubMed ID: 18596668 [Abstract] [Full Text] [Related]
29. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Bak M, Serdaroglu E, Guclu R. Pediatr Nephrol; 2006 Mar 26; 21(3):350-4. PubMed ID: 16382319 [Abstract] [Full Text] [Related]
30. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V, Torregrosa V. Nefrologia; 2008 Mar 26; 28 Suppl 3():67-78. PubMed ID: 19018742 [Abstract] [Full Text] [Related]
31. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation. Al-Gabri S, Zadrazil J, Krejcí K, Horák P, Bachleda P. Transplant Proc; 2005 Mar 26; 37(2):1014-9. PubMed ID: 15848609 [Abstract] [Full Text] [Related]
32. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats. Brzóska MM, Moniuszko-Jakoniuk J. Bone; 2004 Nov 26; 35(5):1180-91. PubMed ID: 15542044 [Abstract] [Full Text] [Related]
33. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Bezemer PD, Bouter LM. J Bone Miner Res; 1995 Aug 26; 10(8):1177-84. PubMed ID: 8585420 [Abstract] [Full Text] [Related]
34. Long-term follow-up of bone mineral density in Addison's disease. Jódar E, Valdepeñas MP, Martinez G, Jara A, Hawkins F. Clin Endocrinol (Oxf); 2003 May 26; 58(5):617-20. PubMed ID: 12699444 [Abstract] [Full Text] [Related]
35. Biochemical bone markers in nephrotic children. Biyikli NK, Emre S, Sirin A, Bilge I. Pediatr Nephrol; 2004 Aug 26; 19(8):869-73. PubMed ID: 15206021 [Abstract] [Full Text] [Related]
36. Uncoupling of Bone Turnover may Compromise Skeletal Health of Young Patients With Haemophilia A. Pergantou H, Papakonstantinou O, Xafaki P, Athanasopoulou H, Balanika A, Kattamis A, Doulgeraki A. J Clin Densitom; 2022 Aug 26; 25(1):89-96. PubMed ID: 34384686 [Abstract] [Full Text] [Related]
37. Relationship between bone formation markers bone alkaline phosphatase, osteocalcin and amino-terminal propeptide of type I collagen and bone mineral density in elderly men. Preliminary results. Lumachi F, Orlando R, Fallo F, Basso SM. In Vivo; 2012 Aug 26; 26(6):1041-4. PubMed ID: 23160690 [Abstract] [Full Text] [Related]
38. Bone mineral density in long-term survivors following pediatric liver transplantation. Guthery SL, Pohl JF, Bucuvalas JC, Alonso MH, Ryckman FC, Balistreri WF, Heubi JE. Liver Transpl; 2003 Apr 26; 9(4):365-70. PubMed ID: 12682887 [Abstract] [Full Text] [Related]
39. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases. Bai XL, Liang TB, Wu LH, Li DL, Geng L, Wang WL, Shen Y, Zhang M, Zheng SS. Transplant Proc; 2007 Dec 26; 39(10):3182-5. PubMed ID: 18089348 [Abstract] [Full Text] [Related]
40. Bone density and metabolism in subjects with microdeletion of chromosome 22q11 (del22q11). Stagi S, Lapi E, Gambineri E, Manoni C, Genuardi M, Colarusso G, Conti C, Chiarelli F, de Martino M, Azzari C. Eur J Endocrinol; 2010 Aug 26; 163(2):329-37. PubMed ID: 20516202 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]